Skip over generic navigation
Skip over primary navigation
Skip over visual
Innovative ideas lead to trend-setting technologies.
Skip over functional column
In 2016, Evonik’s R&D expenditure accumulated to Euro 438 million. We have increased R&D expenditures an average of four percent per year since 2011. Moreover, in the past three years we have spent Euro 158 million on building laboratory capacity and pilot plants. With more than 500 projects in its innovation pipeline, Evonik Industries is meeting the demands of the top megatrends in the areas of health, nutrition, resource efficiency and globalization. The large number of first-time patent applications filed by Evonik places it at the forefront of the specialty chemicals sector. Our total number of patents and patent applications stands at approximately 24,500. In 2016 alone we filed approximately 230 new patents—an average of about five per week. The value of our patent portfolio has increased steadily in recent years.
With the strategic innovation unit to new business.more
The Evonik Science Newsletter for download.more
If you have any question, please mail email@example.com